Prognostic significance and gene expression profiles of p53 mutations in microsatellite-stable Stage III colorectal adenocarcinomas

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Katkoori, Venkat R ^a   Shanmugam, Chandrakumar ^a   Jia, Xu ^a   Vitta, Swaroop P ^a   Sthanam, Meenakshi ^a   Callens, Tom ^b   Messiaen, Ludwine ^b   Chen, Dongquan ^c   Zhang, Bin ^d   Bumpers, Harvey L ^e   Samuel, Temesgen ^f   Manne, Upender ^a,g  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

^f TUSKEGEE UNIVERSITY   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; FORMALDEHYDE; GENOMIC DNA; LEVAMISOLE; LOMUSTINE; MESSENGER RNA; OXALIPLATIN; PARAFFIN; PROTEIN P53; 3 GALACTOSYL N ACETYLGLUCOSAMINIDE 4 ALPHA L FUCOSYLTRANSFERASE; 3-GALACTOSYL-N-ACETYLGLUCOSAMINIDE 4-ALPHA-L-FUCOSYLTRANSFERASE; ACTIN BINDING PROTEIN; DNA BINDING PROTEIN; FUCOSYLTRANSFERASE; LIM PROTEIN; LPAR6 PROTEIN, HUMAN; LYSOPHOSPHATIDIC ACID RECEPTOR; MICROSATELLITE DNA; NERVE PROTEIN; PDLIM3 PROTEIN, HUMAN; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORTER; PLAT PROTEIN, HUMAN; SLC6A8 PROTEIN, HUMAN; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR; TRIM29 PROTEIN, HUMAN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL ADENOMA; COLORECTAL SURGERY; CONTROLLED STUDY; DNA EXTRACTION; DOWN REGULATION; FROZEN SECTION; FUT3 GENE; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; IQGAP3 GENE; KAPLAN MEIER METHOD; LPAR GENE; MICROSATELLITE INSTABILITY; MULTIVARIATE ANALYSIS; NUCLEASE PROTECTION ASSAY; PDLIM3 GENE; PHENOTYPE; PLAT GENE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SLC6A8 GENE; TRIM29 GENE; TUMOR SUPPRESSOR GENE; UNIVARIATE ANALYSIS; UPREGULATION; WILD TYPE; ADENOCARCINOMA; COLORECTAL TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MIDDLE AGED; MUTATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; MALE; MICROFILAMENT PROTEINS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LYSOPHOSPHATIDIC ACID; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856012431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030020     Document Type: Article

References (66)

1. Welter S, Jacobs J, Krbek T, Poettgen C, Stamatis G, (2007) Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 31: 167-172.
2. Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S, (1997) Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80: 2268-2272.
3. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532.
4. Popat S, Houlston RS, (2005) A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer 41: 2060-2070.
5. Jass JR, Young J, Leggett BA, (2002) Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol 17: 17-26.
6. Salahshor S, Koelble K, Rubio C, Lindblom A, (2001) Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest 81: 535-541.
7. Jass JR, Cottier DS, Jeevaratnam P, Pokos V, Holdaway KM, et al. (1995) Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 346: 1200-1201.
8. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M, (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561.
9. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, et al. (2001) Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol 158: 1517-1524.
10. Tang R, Wang JY, Fan CW, Tsao KC, Chen HH, et al. (2004) p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy. Cancer Lett 210: 101-109.
11. Elsaleh H, Powell B, McCaul K, Grieu F, Grant R, et al. (2001) P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma. Clin Cancer Res 7: 1343-1349.
12. Zaanan A, Cuilliere-Dartigues P, Guilloux A, Parc Y, Louvet C, et al. (2010) Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol 21: 772-780.
13. Borresen-Dale AL, Lothe RA, Meling GI, Hainaut P, Rognum TO, et al. (1998) TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival. Clin Cancer Res 4: 203-210.
14. Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, et al. (2006) Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 10: 191-202.
15. Greenblatt MS, Bennett WP, Hollstein M, Harris CC, (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878.
16. Joerger AC, Fersht AR, (2007) Structure-function-rescue: the diverse nature of common p53 cancer mutants. Oncogene 26: 2226-2242.
17. Levine AJ, Finlay CA, Hinds PW, (2004) P53 is a tumor suppressor gene. Cell 116: S67-69, 61p following S69.
18. Liu DP, Song H, Xu Y, (2009) A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 29: 949-956.
19. Powell B, Soong R, Iacopetta B, Seshadri R, Smith DR, (2000) Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Clin Cancer Res 6: 443-451.
20. Mollevi DG, Serrano T, Ginesta MM, Valls J, Torras J, et al. (2007) Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis 28: 1241-1246.
21. Goh HS, Chan CS, Khine K, Smith DR, (1994) p53 and behaviour of colorectal cancer. Lancet 344: 233-234.
22. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, et al. (1996) Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811-814.
23. Kressner U, Inganas M, Byding S, Blikstad I, Pahlman L, et al. (1999) Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol 17: 593-599.
24. Skaug V, Ryberg D, Kure EH, Arab MO, Stangeland L, et al. (2000) p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 6: 1031-1037.
25. Katkoori VR, Jia X, Shanmugam C, Wan W, Meleth S, et al. (2009) Prognostic Significance of p53 Codon 72 Polymorphism Differs with Race in Colorectal Adenocarcinoma. Clin Cancer Res 15: 2406-2416.
26. Chittenden TW, Howe EA, Culhane AC, Sultana R, Taylor JM, et al. (2008) Functional classification analysis of somatically mutated genes in human breast and colorectal cancers. Genomics 91: 508-511.
27. Sood AK, Skilling JS, Buller RE, (1997) Ovarian cancer genomic instability correlates with p53 frameshift mutations. Cancer Res 57: 1047-1049.
28. Popat S, Wort R, Houlston RS, (2006) Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. BMC Cancer 6: 150.
29. Perucho M, (1996) Cancer of the microsatellite mutator phenotype. Biol Chem 377: 675-684.
30. Jones AM, Douglas EJ, Halford SE, Fiegler H, Gorman PA, et al. (2005) Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24: 118-129.
31. Su GH, Bansal R, Murphy KM, Montgomery E, Yeo CJ, et al. (2001) ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma. Proc Natl Acad Sci U S A 98: 3254-3257.
32. Kopnin PB, Agapova LS, Kopnin BP, Chumakov PM, (2007) Repression of sestrin family genes contributes to oncogenic Ras-induced reactive oxygen species up-regulation and genetic instability. Cancer Res 67: 4671-4678.
33. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, et al. (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629.
34. Draghici S, Khatri P, Eklund AC, Szallasi Z, (2006) Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22: 101-109.
35. Skrzypczak M, Goryca K, Rubel T, Paziewska A, Mikula M, et al. (2010) Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 5.
36. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, et al. (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93: 1054-1061.
37. Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, et al. (2007) Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A 104: 13732-13737.
38. Sanchez-Palencia A, Gomez-Morales M, Gomez-Capilla JA, Pedraza V, Boyero L, et al. (2010) Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. International Journal of Cancer: Early on-line version.
39. Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, et al. (2010) Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients. Thyroid 20: 475-487.
40. Thakkar AD, Raj H, Chakrabarti D, Ravi S, Saravanan N, et al. (2010) Identification of Gene Expression Signature in Estrogen Receptor Positive Breast Carcinoma. Biomarkers in Cancer 2: 1-15.
41. Yin X, Rana K, Ponmudi V, King MR, (2010) Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res 345: 2334-2342.
42. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. (2001) The tripartite motif family identifies cell compartments. EMBO J 20: 2140-2151.
43. Dho SH, Kwon KS, (2003) The Ret finger protein induces apoptosis via its RING finger-B box-coiled-coil motif. J Biol Chem 278: 31902-31908.
44. Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, et al. (2007) Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer. Ann Surg Oncol 14: 2543-2549.
45. Bashour AM, Fullerton AT, Hart MJ, Bloom GS, (1997) IQGAP1, a Rac- and Cdc42-binding protein, directly binds and cross-links microfilaments. J Cell Biol 137: 1555-1566.
46. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K, (2005) IQGAP1: a key regulator of adhesion and migration. J Cell Sci 118: 2085-2092.
47. White CD, Brown MD, Sacks DB, (2009) IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett 583: 1817-1824.
48. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, (2008) IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat Cell Biol 10: 971-978.
49. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, et al. (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 979-994.
50. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, et al.eds. (2010) American Joint Committee on Cancer, American Cancer Society: AJCC Cancer Staging Manual. 7th ed New York, NY Springer-Verlag.
51. WHO International classification of diseases for oncology.; 1990; Geneva. World Health Organization.
52. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257.
53. Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, et al. (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61: 4545-4549.
54. Wagner F, Radelof U, (2007) Performance of different small sample RNA amplification techniques for hybridization on Affymetrix GeneChips. J Biotechnol 129: 628-634.
55. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F, (2004) A Model-Based Background Adjustment for Oligonucleotide Expression Arrays. Journal of the American Statistical Association 99: 909-917.
56. Martel RR, Botros IW, Rounseville MP, Hinton JP, Staples RR, et al. (2002) Multiplexed screening assay for mRNA combining nuclease protection with luminescent array detection. Assay Drug Dev Technol 1: 61-71.
57. Roberts RA, Sabalos CM, LeBlanc ML, Martel RR, Frutiger YM, et al. (2007) Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma. Lab Invest 87: 979-997.
58. Katkoori VR, Jia X, Chatla C, Kumar S, Ponnazhagan S, et al. (2008) Clinical significance of a novel single nucleotide polymorphism in the 5′ untranslated region of the Rabphillin-3A-Like gene in colorectal adenocarcinoma. Front Biosci 13: 1050-1061.
59. Manne U, Myers RB, Moron C, Poczatek RB, Dillard S, et al. (1997) Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74: 346-358.
60. Shanmugam C, Jhala NC, Katkoori V, Wan W, Meleth S, et al. (2010) Prognostic value of MUC4 expression in colorectal adenocarcinomas. Cancer: Published Online: 29 Apr 2010.
61. Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI, (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132: 371-374; discussion 374-375.
62. Fleiss J, (1981) Statistical methods for rates and proportions New York, NY John Wiley and Sons.
63. Allison PD, SAS Institute. (1995) Survival analysis using the SAS system: a practical guide Cary, NC SAS Institute pp. viii, 292.
64. Kaplan E MP, (1958) Non-parametric estimation from incomplete observations. J AM Stat Assoc pp. 53.
65. Cox DR, (1972) Regression models and life tables. J Roy Stat Soc 34: 187-220.
66. Mooney CZ, Duval RD, (1993) Bootstrapping: A non-parametric approach to statistical inference. In: McElroy S, editors. Newbury Park, CA Sage.